Subramanian J - Search Results

1

Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data.

Simon RM, Subramanian J, Li MC, Menezes S. Simon RM, et al. Among authors: subramanian j. Brief Bioinform. 2011 May;12(3):203-14. doi: 10.1093/bib/bbr001. Epub 2011 Feb 15. Brief Bioinform. 2011. PMID: 21324971 Free PMC article.

2

Gene expression-based prognostic signatures in lung cancer: ready for clinical use?

Subramanian J, Simon R. Subramanian J, et al. J Natl Cancer Inst. 2010 Apr 7;102(7):464-74. doi: 10.1093/jnci/djq025. Epub 2010 Mar 16. J Natl Cancer Inst. 2010. PMID: 20233996 Free PMC article. Review.

3

An evaluation of resampling methods for assessment of survival risk prediction in high-dimensional settings.

Subramanian J, Simon R. Subramanian J, et al. Stat Med. 2011 Mar 15;30(6):642-53. doi: 10.1002/sim.4106. Epub 2010 Dec 1. Stat Med. 2011. PMID: 21337359

4

What should physicians look for in evaluating prognostic gene-expression signatures?

Subramanian J, Simon R. Subramanian J, et al. Nat Rev Clin Oncol. 2010 Jun;7(6):327-34. doi: 10.1038/nrclinonc.2010.60. Epub 2010 Apr 27. Nat Rev Clin Oncol. 2010. PMID: 20421890 Review.

5

The Bayesian basket design for genomic variant-driven phase II trials.

Simon R, Geyer S, Subramanian J, Roychowdhury S. Simon R, et al. Among authors: subramanian j. Semin Oncol. 2016 Feb;43(1):13-18. doi: 10.1053/j.seminoncol.2016.01.002. Epub 2016 Jan 18. Semin Oncol. 2016. PMID: 26970120 Free article.

6

Overfitting in prediction models - is it a problem only in high dimensions?

Subramanian J, Simon R. Subramanian J, et al. Contemp Clin Trials. 2013 Nov;36(2):636-41. doi: 10.1016/j.cct.2013.06.011. Epub 2013 Jun 27. Contemp Clin Trials. 2013. PMID: 23811117

7

Clinical Evolution of Epithelial-Mesenchymal Transition in Human Carcinomas.

Navas T, Kinders RJ, Lawrence SM, Ferry-Galow KV, Borgel S, Hollingshead MG, Srivastava AK, Alcoser SY, Makhlouf HR, Chuaqui R, Wilsker DF, Konaté MM, Miller SB, Voth AR, Chen L, Vilimas T, Subramanian J, Rubinstein L, Kummar S, Chen AP, Bottaro DP, Doroshow JH, Parchment RE. Navas T, et al. Among authors: subramanian j. Cancer Res. 2020 Jan 15;80(2):304-318. doi: 10.1158/0008-5472.CAN-18-3539. Epub 2019 Nov 15. Cancer Res. 2020. PMID: 31732654 Free PMC article.

8

Population pharmacokinetic analysis to identify the possibility of interaction between anti-cancer agents.

Subramanian J, Damre A, Rohatagi S. Subramanian J, et al. Indian J Cancer. 2015 Jul-Sep;52(3):461-5. doi: 10.4103/0019-509X.176692. Indian J Cancer. 2015. PMID: 26905169 Free article.

9

Comparison of effects of anti-angiogenic agents in the zebrafish efficacy-toxicity model for translational anti-angiogenic drug discovery.

Chimote G, Sreenivasan J, Pawar N, Subramanian J, Sivaramakrishnan H, Sharma S. Chimote G, et al. Among authors: subramanian j. Drug Des Devel Ther. 2014 Aug 19;8:1107-23. doi: 10.2147/DDDT.S55621. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25170251 Free PMC article.

10

A novel computational analysis of ligand-induced conformational changes in the ATP binding sites of cyclin dependent kinases.

Subramanian J, Sharma S, B-Rao C. Subramanian J, et al. J Med Chem. 2006 Sep 7;49(18):5434-41. doi: 10.1021/jm060172s. J Med Chem. 2006. PMID: 16942017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters